|
1
|
Fernandes SM, Marelli A, Hile DM and
Daniels CJ: Access and delivery of adult congenital heart disease
care in the United States: Quality driven team based care. Cardiol
Clin. 38:295–304. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burchill LJ, Lee MGY, Nguyen VP and Stout
KK: Heart failure in adult congenital heart disease. Cardiol Clin.
38:457–469. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schulkey CE, Regmi SD, Magnan RA, Danzo
MT, Luther H, Hutchinson AK, Panzer AA, Grady MM, Wilson DB and Jay
PY: The maternal-age-associated risk of congenital heart disease is
modifiable. Nature. 520:230–233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ,
Lemke K, Chen Y, Chatterjee B, Devine W, Damerla RR, et al: Global
genetic analysis in mice unveils central role for cilia in
congenital heart disease. Nature. 521:520–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bruneau BG: The developmental genetics of
congenital heart disease. Nature. 451:943–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakhi R, Kauling RM, Theuns DA,
Szili-Torok T, Bhagwandien RE, van den Bosch AE, Cuypers JAAE,
Roos-Hesselink JW and Yap SC: Early detection of ventricular
arrhythmias in adults with congenital heart disease using an
insertable cardiac monitor (EDVA-CHD study). Int J Cardiol.
305:63–69. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meller CH, Grinenco S, Aiello H, Córdoba
A, Sáenz-Tejeira MM, Marantz P and Otaño L: Congenital heart
disease, prenatal diagnosis and management. Arch Argent Pediatr.
118:e149–e161. 2020.(In English, Spanish). PubMed/NCBI
|
|
8
|
Bishop L, Lansbury A and English K: Adult
congenital heart disease and pregnancy. BJA Educ. 18:23–29. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shum KK, Gupta T, Canobbio MM, Durst J and
Shah SB: Family planning and pregnancy management in adults with
congenital heart disease. Prog Cardiovasc Dis. 61:336–346. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmidt AB, Lund M, Corn G, Halldorsson
TI, Øyen N, Wohlfahrt J, Olsen SF and Melbye M: Dietary glycemic
index and glycemic load during pregnancy and offspring risk of
congenital heart defects: A prospective cohort study. Am J Clin
Nutr. 111:526–535. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Costello A, Lao NT, Barron N and Clynes M:
Reinventing the wheel: Synthetic circular RNAs for mammalian cell
engineering. Trends Biotechnol. 38:217–230. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Verduci L, Strano S, Yarden Y and Blandino
G: The circRNA-microRNA code: Emerging implications for cancer
diagnosis and treatment. Mol Oncol. 13:669–680. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Yang T and Xiao J: Circular RNAs:
Promising biomarkers for human diseases. EBioMedicine. 34:267–274.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bolha L, Ravnik Glavac M and Glavac D:
Circular RNAs: Biogenesis, function, and a role as possible cancer
biomarkers. Int J Genomics. 2017:62183532017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Y, Zhang C, Xiong J and Ren H:
Emerging important roles of circRNAs in human cancer and other
diseases. Genes Dis. 8:412–423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thum T, Gross C, Fiedler J, Fischer T,
Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et
al: MicroRNA-21 contributes to myocardial disease by stimulating
MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu N, Bezprozvannaya S, Williams AH, Qi
X, Richardson JA, Bassel-Duby R and Olson EN: MicroRNA-133a
regulates cardiomyocyte proliferation and suppresses smooth muscle
gene expression in the heart. Genes Dev. 22:3242–3254. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu J, Li J, Liu H, Yin J, Zhang M, Yu Z
and Miao H: Circulating plasma circular RNAs as novel diagnostic
biomarkers for congenital heart disease in children. J Clin Lab
Anal. 33:e229982019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clavijo PE, Friedman J, Robbins Y, Moore
EC, Smith E, Zauderer M, Evans EE and Allen CT: Semaphorin4D
inhibition improves response to immune-checkpoint blockade via
attenuation of MDSC recruitment and function. Cancer Immunol Res.
7:282–291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wada N, Wang B, Lin NH, Laslett AL,
Gronthos S and Bartold PM: Induced pluripotent stem cell lines
derived from human gingival fibroblasts and periodontal ligament
fibroblasts. J Periodontal Res. 46:438–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rowntree RK and McNeish JD: Induced
pluripotent stem cells: Opportunities as research and development
tools in 21st century drug discovery. Regen Med. 5:557–568. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Casiraghi A, Ardovino P, Minghetti P,
Botta C, Gattini A and Montanari L: Semisolid formulations
containing dimethyl sulfoxide and alpha-tocopherol for the
treatment of extravasation of antiblastic agents. Arch Dermatol
Res. 299:201–207. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Santos NC, Figueira-Coelho J,
Martins-Silva J and Saldanha C: Multidisciplinary utilization of
dimethyl sulfoxide: Pharmacological, cellular, and molecular
aspects. Biochem Pharmacol. 65:1035–1041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kehat I, Kenyagin-Karsenti D, Snir M,
Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J
and Gepstein L: Human embryonic stem cells can differentiate into
myocytes with structural and functional properties of
cardiomyocytes. J Clin Invest. 108:407–414. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Inamdar MS, Venu P, Srinivas MS, Rao K and
VijayRaghavan K: Derivation and characterization of two sibling
human embryonic stem cell lines from discarded grade III embryos.
Stem Cells Dev. 18:423–433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pal R, Mamidi MK, Das AK and Bhonde R:
Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation
potential of human embryonic stem cells. Arch Toxicol. 86:651–661.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Behrens AN, Iacovino M, Lohr JL, Ren Y and
Martin CM: Nkx2 5 mediates differential cardiac differentiation
through interaction with Hoxa10. Stem Cells Dev. 22:2211–2220.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao N, Huang Y, Zheng J, Spencer CI, Zhang
Y, Fu JD, Nie B, Xie M, Zhang M, Wang H, et al: Conversion of human
fibroblasts into functional cardiomyocytes by small molecules.
Science. 352:1216–1220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Z and Huang J: Neuregulin-1 increases
connexin-40 and connexin-45 expression in embryonic stem
cell-derived cardiomyocytes. Appl Biochem Biotechnol. 174:483–493.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Behrens AN, Iacovino M, Lohr JL, Ren Y,
Zierold C, Harvey RP, Kyba M, Garry DJ and Martin CM: Nkx2-5
mediates differential cardiac differentiation through interaction
with Hoxa10. Stem Cells Dev. 22:2211–2220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao N, Huang Y, Zheng J, Spencer CI, Zhang
Y, Fu JD, Nie B, Xie M, Zhang M, Wang H, et al: Conversion of human
fibroblasts into functional cardiomyocytes by small molecules.
Science. 352:1216–1220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Solé C and Lawrie CH: Circular RNAs and
cancer: Opportunities and challenges. Adv Clin Chem. 99:87–146.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sucharov CC, Miyamoto SD and Garcia AM:
Circulating microRNAs as biomarkers in pediatric heart diseases.
Prog Pediatr Cardiol. 49:50–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kandettu A, Radhakrishnan R, Chakrabarty
S, Sriharikrishnaa S and Kabekkodu SP: The emerging role of miRNA
clusters in breast cancer progression. Biochim Biophys Acta Rev
Cancer. 1874:1884132020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu KJ: The role of miRNA biogenesis and
DDX17 in tumorigenesis and cancer stemness. Biomedical Journal.
43:107–114. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tesfaye AA, Azmi AS and Philip PA: miRNA
and gene expression in pancreatic ductal adenocarcinoma. Am J
Pathol. 189:58–70. 2019. View Article : Google Scholar : PubMed/NCBI
|
